Should we use inhaled nitric oxide in acute respiratory distress syndrome?
M Sivaloganathan, Robert J. Stephens
Abstract
M Sivaloganathan, Robert J. Stephens
Abstract
Nitric oxide produced in the lung causes pulmonary vasodilation. In acute respiratory distress syndrome, ventilation—perfusion mismatch produces arterial hypoxaemia while increased pulmonary vascular resistance causes pulmonary hypertension. In theory, nitric oxide preferentially reaches ventilated alveoli, selectively vasodilating vessels, thus improving oxygenation and reducing pulmonary vascular resistance. But should we use nitric oxide in practice?
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Nitric oxide produced in the lung causes pulmonary vasodilation. In acute respiratory distress syndrome, ventilation—perfusion mismatch produces arterial hypoxaemia while increased pulmonary vascular resistance causes pulmonary hypertension. In theory, nitric oxide preferentially reaches ventilated alveoli, selectively vasodilating vessels, thus improving oxygenation and reducing pulmonary vascular resistance. But should we use nitric oxide in practice?
Key concepts: Nitric oxide, Medicine, Acute respiratory distress, Vascular resistance, Pulmonary hypertension, Anesthesia, Oxygenation, Vasodilation